Health CareHealth Care Equipment & Services
  • Price (GBX)1,355.00
  • Today's Change7.00 / 0.52%
  • Shares traded83.16k
  • 1 Year change79.00%
  • Beta0.4498
Data delayed at least 20 minutes, as of Aug 31 2016 16:35 BST.
More ▼

Key statistics

NMC Health PLC (NMC:LSE) set a new 52-week high during today's trading session when it reached 1,369.00. Over this period, the share price is up 83.11%.
52-week range
Today
725.00Sep 03 20151,369.00Aug 31 2016
Markit short selling activity
Low
Med
High
Open1,333.00
High1,369.00
Low1,333.00
Bid1,355.00
Offer1,358.00
Previous close1,355.00
Average volume88.25k
Shares outstanding185.71m
Free float61.27m
P/E (TTM)31.37
Market cap2.51bn GBP
EPS (TTM)0.4304 GBP
Annual div (IAD)6.20 GBX
Annual div yield (IAD)0.46%
Div ex-dateMay 19 2016
Div pay-dateJun 20 2016
Data delayed at least 20 minutes, as of Aug 31 2016 16:35 BST.
More ▼

Investors Chronicle View

The last IC recommendation on NMC Health PLC shares was Buy at 1,321.00 on 30 Aug 2016Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.